Advanced Enzyme Technologies Limited has announced that CRISIL Ratings has reaffirmed its outstanding credit ratings for the company’s bank loan facilities. The company holds a total rated bank loan facility of ₹100 crore, maintaining its stable financial outlook. These reaffirmed ratings reflect the company’s consistent ability to meet its debt obligations and provide investors and stakeholders with confidence regarding its financial stability and ongoing debt management practices.
Rating Summary
Following a recent review, CRISIL Ratings has maintained the credit ratings for Advanced Enzyme Technologies Limited. The assessment covers the company’s total bank loan facilities amounting to ₹100 crore. The reaffirmation serves as a testament to the company’s operational strength and its disciplined approach toward financial management.
Details of Rated Facilities
The reaffirmation confirms the following ratings for the company’s credit profile:
- Long-Term Rating: CRISIL A+/Stable (Reaffirmed)
- Short-Term Rating: CRISIL A1+ (Reaffirmed)
Breakdown of Credit Exposure
The company’s credit structure includes various facilities across multiple banking partners. Key components of these facilities include:
- Overdraft Facilities: ₹12.5 crore provided by HDFC Bank Limited.
- Letter of Credit & Bank Guarantees: ₹2.5 crore provided by HDFC Bank Limited.
- Pre-Shipment Packing Credits: ₹15 crore via Citibank N.A. and ₹5 crore via DBS Bank Limited.
- Proposed Facilities: The total includes ₹40 crore in proposed long-term bank loans and ₹25 crore in proposed working capital facilities.
These facilities are designed with flexibility, including provisions for interchangeability across various instruments like Working Capital Demand Loans (WCDL), Cash Credit (CC), and various export-related credit instruments to support the company’s working capital requirements effectively.
Source: BSE
